NIKI

Niki BioSolutions, Inc.

4.62 USD

Last updated Oct 7, 18:18 UTC

Yesterday HIGH

$4.96

Yesterday LOW

$4.69

52w HIGH

$25.9

52w LOW

$4.52

EPS

1.00

PE

4.62

Next Earnings

Oct 20, 2026

Overview News Government Trades Fundamentals

Niki BioSolutions, Inc. stock is down -26.43% since 30 days ago. The next earnings date is Oct 20, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 7 October’s closed higher than September.

Benzinga Newsdesk

Mon Sep 14, 2026

Niki BioSolutions' DiamiR Announces Engagement Of Fios Genomics For Bioinformatics And Biostatistics Analysis Supporting Alzheimer's Disease Program; Terms Not Disclosed
Benzinga Insights

Fri Sep 4, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68.
Benzinga Insights

Thu Aug 20, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.
Benzinga Insights

Thu Jul 23, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology (NASDAQ:ZYBT) shares
Benzinga Newsdesk

Thu Jul 23, 2026

Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.
Benzinga Newsdesk

Thu Jul 23, 2026

Niki BioSolutions’ DiamiR Biosciences Agrees To Provide Progressive Medical Research With Apolipoprotein E Genotyping Services In Support Of Ongoing Clinical And Translational Research Programs

Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research ProgramsNEW HAVEN, CT and PRINCETON, NJ, July 23, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc., a clinical-stage life
Benzinga Insights

Tue Jul 21, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-market session. The market value of their outstanding shares is at $6.2 million. Apimeds Pharmaceuticals (AMEX:APUS)
Benzinga Newsdesk

Tue Jul 21, 2026

Niki BioSolutions Shares Halted On Circuit Breaker To The Upside, Stock Now Up 13.36%
Benzinga Insights

Tue Jul 21, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's regular session. The company's market cap stands at $36.8 million. Wellgistics Health (NASDAQ:WGRX) shares increased